Cargando…

Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study

OBJECTIVES: The objective of the study was to validate the Ankylosing Spondylitis Disease Activity Score (ASDAS) based on a quick quantitative C-reactive protein (qCRP) assay (ASDAS-Q) in a multicentre, prospective, cross-sectional study in patients with axial spondyloarthritis (axial SpA). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Proft, Fabian, Schally, Julia, Brandt, Henning Christian, Brandt-Juergens, Jan, Rüdiger Burmester, Gerd, Haibel, Hildrun, Käding, Henriette, Karberg, Kirsten, Lüders, Susanne, Muche, Burkhard, Protopopov, Mikhail, Rademacher, Judith, Rios Rodriguez, Valeria, Torgutalp, Murat, Verba, Maryna, Zinke, Silke, Poddubnyy, Denis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	A Glance into the Future of Rheumatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972926/ https://www.ncbi.nlm.nih.gov/pubmed/35368376 http://dx.doi.org/10.1177/1759720X221085951

Ejemplares similares

Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study
por: Proft, Fabian, et al.
Publicado: (2022)

Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study
por: Schally, Julia, et al.
Publicado: (2022)

Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial
por: Proft, Fabian, et al.
Publicado: (2021)

Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis
por: Torgutalp, Murat, et al.
Publicado: (2022)

A glance into the future of diagnosis and treatment of spondyloarthritis
por: Navarro-Compán, Victoria, et al.
Publicado: (2022)

A broad look into the future of rheumatoid arthritis
por: Mucke, Johanna, et al.
Publicado: (2022)

A glimpse into the future of systemic lupus erythematosus
por: Aringer, Martin, et al.
Publicado: (2022)

Osteoporosis in 10 years time: a glimpse into the future of osteoporosis
por: Adami, Giovanni, et al.
Publicado: (2022)

Future challenges in rheumatology – is telemedicine the solution?
por: de Thurah, Annette, et al.
Publicado: (2022)

Psoriatic arthritis: prospects for the future
por: Hackett, Simon, et al.
Publicado: (2022)

A glance into the future of myositis therapy
por: Chiapparoli, Ilaria, et al.
Publicado: (2022)

Looking ahead: giant-cell arteritis in 10 years time
por: Bond, Milena, et al.
Publicado: (2022)

Sjögren syndrome: looking forward to the future
por: Zandonella Callegher, Sara, et al.
Publicado: (2022)

A glance into the future of gout
por: Sivera, Francisca, et al.
Publicado: (2022)

Big data analyses and individual health profiling in the arena of rheumatic and musculoskeletal diseases (RMDs)
por: De Cock, Diederik, et al.
Publicado: (2022)

A broad look into the future of systemic sclerosis
por: Riemekasten, Gabriela, et al.
Publicado: (2022)

A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Casal Moura, Marta, et al.
Publicado: (2022)

ASDAS is associated with both the extent and intensity of DW-MRI spinal inflammation in active axial spondyloarthritis
por: Chung, Ho Yin, et al.
Publicado: (2019)

Study protocol: Comparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of Structural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) – an open-label randomized controlled multicenter trial
por: Proft, Fabian, et al.
Publicado: (2017)

Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial
por: Proft, Fabian, et al.
Publicado: (2021)

The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
por: Chen, Yi-Hsing, et al.
Publicado: (2022)

The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry
por: Kim, Jinhyun, et al.
Publicado: (2023)

Relation of α(2)-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis
por: Hoppe, Berthold, et al.
Publicado: (2020)

Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysis
por: Hoppe, Berthold, et al.
Publicado: (2021)

Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis
por: Castrejón, Isabel, et al.
Publicado: (2016)

Early achievement of ASDAS clinical response is associated with long-term improvements in metrological outcomes in patients with ankylosing spondylitis treated with TNF-α blockers
por: Nam, Eon Jeong, et al.
Publicado: (2020)

Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO
por: Llop, Maria, et al.
Publicado: (2022)

Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort
por: Protopopov, Mikhail, et al.
Publicado: (2017)

Deep learning for detection of radiographic sacroiliitis: achieving expert-level performance
por: Bressem, Keno K., et al.
Publicado: (2021)

Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR
por: Maksymowych, Walter P., et al.
Publicado: (2021)

Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate
por: Poddubnyy, Denis, et al.
Publicado: (2020)

ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis
por: van der Heijde, Désirée, et al.
Publicado: (2016)

Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives
por: Ambler, William G., et al.
Publicado: (2022)

Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany
por: Krüger, Klaus, et al.
Publicado: (2018)

Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA)
por: Emery, Paul, et al.
Publicado: (2018)

Newly identified aspects of tumor suppression by RB
por: Viatour, Patrick, et al.
Publicado: (2011)

Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments
por: Draoui, Nihed, et al.
Publicado: (2011)

Technical approaches for mouse models of human disease
por: Justice, Monica J., et al.
Publicado: (2011)

Brain–gut–adipose-tissue communication pathways at a glance
por: Yi, Chun-Xia, et al.
Publicado: (2012)

The adipose organ at a glance
por: Cinti, Saverio
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q3j0f7scg6uorabbj02qr7k2vf